Primatesta P, Plana E, Moore A. A quantitative approach to benefit-risk assessment: an example with lumiracoxib. Presented at the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2011. Chicago, IL.


Abstract not available at this time.

Share on: